These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16982769)

  • 41. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ; Janssen A; Schmidt R; Geisslinger G; Grösch S
    FASEB J; 2005 Aug; 19(10):1353-5. PubMed ID: 15946992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
    Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
    Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-terminal truncation mutations of adenomatous polyposis coli are associated with primary cilia defects.
    Song L; Jia Y; Zhu W; Newton IP; Li Z; Li W
    Int J Biochem Cell Biol; 2014 Oct; 55():79-86. PubMed ID: 25150829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin.
    De Schepper S; Bruwiere H; Verhulst T; Steller U; Andries L; Wouters W; Janicot M; Arts J; Van Heusden J
    J Pharmacol Exp Ther; 2003 Feb; 304(2):881-8. PubMed ID: 12538846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.
    Feng J; Cen J; Li J; Zhao R; Zhu C; Wang Z; Xie J; Tang W
    Cell Adh Migr; 2015; 9(6):495-501. PubMed ID: 26632346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.
    Liu HF; Hu HC; Chao JI
    Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU.
    Liu G; Hu X; Chakrabarty S
    Int J Cancer; 2010 Feb; 126(3):631-9. PubMed ID: 19621386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
    Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
    J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
    Ma H; Nguyen C; Lee KS; Kahn M
    Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
    Pathil A; Armeanu S; Venturelli S; Mascagni P; Weiss TS; Gregor M; Lauer UM; Bitzer M
    Hepatology; 2006 Mar; 43(3):425-34. PubMed ID: 16583461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.
    Armeanu S; Pathil A; Venturelli S; Mascagni P; Weiss TS; Göttlicher M; Gregor M; Lauer UM; Bitzer M
    J Hepatol; 2005 Feb; 42(2):210-7. PubMed ID: 15664246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
    Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2009 Feb; 16(2):481-6. PubMed ID: 19030935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
    Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
    Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
    Shelton DN; Sandoval IT; Eisinger A; Chidester S; Ratnayake A; Ireland CM; Jones DA
    Cancer Res; 2006 Aug; 66(15):7571-7. PubMed ID: 16885356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.